Japan: International headwinds contrast domestic resilience

On July 1, the BoJ has published its Tankan report (details on July 2),
which covers business confidence and investment tendencies on the
basis of a large sample of 9970 manufacturing and non-
manufacturing enterprises. The main upshot is that Japanese firms
have increasingly come under pressure from international
headwinds.

Highlights:

  • Over the last days, two different business confidence surveys highlighted the rising dichotomy of foreign and domestic demand in the Japanese economy.
  • The BoJ’s Tankan report showed another drop of business confidence within the largely export oriented manufacturing sector while the mood among large domestic non-manufacturers even slightly increased.
  • Japan’s manufacturing PMI fell back again mainly driven by the export orders component. By contrast, the service PMI (released today) even edged up.
  • The reports highlight our call that any key rate cut by the Bank of Japan (BoJ) will be dominated by international developments rather than domestic forces.
  • Recently, some members of the policy board voiced their concerns about the international environment, hinting at a lengthening of the BoJ’s forward guidance beyond spring 2020. However, regarding more substantial measures, the BoJ may want to await more information of the H2 2019 development. This argues for more BoJ action towards the end of the year.

Download the full publication below

JAPAN: INTERNATIONAL HEADWINDS CONTRAST DOMESTIC RESILIENCE

RELATED INSIGHTS

CHINA’S RECOVERY CONTINUED BUT A BIT SOFTER THAN EXPECTED
China's economic recovery continued in Q3 2020, although a bit softer than expected. Real GDP growth rose to 4.9% yoy, slightly below the Reuters consensus expectation of 5.2% yoy, but still a substantial upturn from the 3.2% yoy in Q2. On a quarterly base, growth dynamics softened to 2.7% qoq, after 11.7% qoq and -10% qoq in the two previous quarters.
Citywire video-interview with Peter Marber
Watch Peter Marber, fund manager of this global, non-directional, long/short approach to Emerging Markets debt, in a video-interview by Citywire.
COVID-19 FACTS & FIGURES
According to the IMF’s Managing Director, strong international cooperation on coronavirus vaccine could speed up the world economic recovery and add $9 trillion to global income by 2025. A WHO trial found that Remdesivir, Hydroxychloroquine, Lopinavir and Interferon have little or no effect on hospitalized Covid-19 patients. Gilead Sciences has questioned the findings of the WHO study saying data appeared inconsistent.